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Abstract
OBJECTIVE: To investigate the effects of Zhi Zi
(Fructus Gardeniae) on non-alcoholic fatty liver dis-
ease (NAFLD) induced by a high-fat diet in the rat.
METHODS: A rat model of NAFLD was established
using a high-fat diet. Twenty one rats were random-
ly divided into a normal group, a model group and
a Zhi Zi treatment group, 7 rats per group. Drinking
water and the drug were intragastrically adminis-
trated for 5 weeks. Samples were then taken to ob-
serve pathological changes of the liver tissue (HE
staining); changes in the fat metabolism pathway e.
g. triglyceride (TG) and free fatty acid (FFA) content;
alterations in liver function, i.e. serum alanine ami-
notransferase (ALT) and aspartate aminotransferase
(AST) activity; and differences in tumor necrosis fac-
tor α (TNF-α) and P-IkB protein expression in the liv-
er tissue.
RESULTS: Fatty degeneration and vacuole-like
changes of different degrees occurred in hepatic
cells of the model group. Markers for fat metabo-
lism, serum ALT and AST activities, and expression
of TNF-α and P-IkB proteins in liver tissue signifi-
cantly increased. Fat metabolism in the Zhi Zi
group significantly reduced, as shown by a drop in
marker levels. Serum ALT and AST activities, and ex-
pression of TNF-α, P-IkB proteins in liver tissue were
also significantly decreased in this group.
CONCLUSION: Zhi Zi has a very strong inhibitory
action on lipidosis and inflammatory injury in the
rat model of NAFLD. This mechanism may possibly
be related to the inhibition of the free fatty acid me-
tabolism pathway.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Morbidity from non-alcoholic fatty liver disease
(NAFLD) has increased year by year, given changes in
people's lifestyle, diet and other factors. NAFLD has,
therefore, become a frequently encountered disease se-
verely threatening people's health[1]. Therefore, active
prevention and treatment of NAFLD is of important
social and economic significance. On the basis of past
clinical practice, we perfomed a pharmacodynamic
study on a Yin Chen Hao Decoction in an experimen-
tal fatty liver model. These studies indicated that this
decoction had anti-fatty liver pharmacological effects
which were achieved through multiple pathways and
targets. These included regulating lipid metabolism, an-
ti-inflammation, anti-lipid peroxidative injury, and pre-
vention of hepatic toxic injury[2]. We found, using a
mathematical model the "uniform design method",
that Zhi Zi (Fructus Gardeniae) played a major role in
the actions of the Yin Chen Hao Decoction. The best
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effective dose was 0.15 g (adult dose, 9 g)[3,4]. To verify
the pharmacological effects of Zhi Zi (Fructus Gardeni-
ae) on NAFLD, this study established a rat model of
NAFLD using high fat feed. We investigated the mech-
anism of Zhi Zi (Fructus Gardeniae) activity on the
free fatty acid metabolism pathway to determine its use
in preventing and treating NAFLD.
MATERIALS ANDMETHODS
Experimental animals
Twenty one Sprague Dawley male rats, (sanitary de-
gree, weighing 180±10 g), were purchased from Shang-
hai Silaike Experimental Animals Co., Ltd (Shanghai,
China), license No: SCXK (Hu) 2007_0005. They
were raised in the experimental Animal Center of the
Medical College, Xiamen University (Xiamen, China).
Drugs and reagents
Prepared herbal pieces of Zhi Zi (Fructus Gardeniae)
were purchased from Tong Ren Tang Co. Ltd (Beijing,
China), and decocted in water using traditional meth-
ods. The decoction was concentrated to 0.15 g crude
drug/mL, and refrigerated for use. Triglycerides (TG;
Cat No. F001-1), free fatty acids (FFA; Cat No.
20100110), serum alanine aminotransferase (ALT; Cat
No. 20100708), and aspartate aminotransferase (AST;
Cat No. 20100708) kits were purchased from Nanjing
Jiancheng Bioengineer Co (Nanjing, China). Rat liver
tissue activated protein kinase (AMPK; Cat No.
QRCT-3013321030223EIA\ULT), fatty acid synthase
(FAS; Cat No. QRCT-3013321033311EIA\ULT), ace-
tyl CoA carboxylase (ACCase; Cat No.
QRCT-3013321031322EIA\ULT), and Malony1 CoA
(Cat No. QRCT-3013321030221EIA\ULT) ELISA
kits were purchased from the ADL Company (Bloom-
ington, MN, USA). P-IkB antibody (Cat No.9246),
TNF-α antibody (Cat No. 06-480), monoclonal GAP-
DH antibody (Lot No. KC-5G5), and monoclonal II
antibody (Lot No. 64356) were purchased from Santa
Cruz Biotechnology, Ltd. (Santa Cruz, CA., USA).
Animals
Twenty one rats were randomly divided into a model
group (n=14), which were raised on high fat feed
(83.25% basic feed, 10% lard, 1.5% cholesterol, 0.2%
sodium deoxycholate, 5% sugar, 0.05% prothio-pyrim-
idine), and a normal group (n=7), which were raised
with normal feed. From the 6th day, rats in the model
group were further randomly divided into a model
group and a Zhi Zi treatment group, 7 rats in each
group. The rats in the Zhi Zi group were intragastrical-
ly administered Zhi Zi (Fructus Gardeniae; 1 mL/100
g body weight containing 0.15 g crude drug/mL), once
each day. Rats in the model group and the normal
group were given drinking water (1 mL/100 g). Rats
still received their respective feeds during the experi-
mental phase of the study. Treatment was given for 5
weeks and after the last administration, the rats were
fasted for 12 h with water supplied. Rats were also
weighed and anesthetized with intraperitoneal injec-
tion of 2% pentobarbital (3 mL/kg body weight). The
abdomen was then open, and blood was taken from
the inferior vena cava 2 h after the fasting period. The
blood was then centrifuged at 4°C for 15 min at 3000r/
min. The supernatant was taken and stored at -80°C.
The liver was removed and two small pieces in the
same position on the right lobe of the liver were taken
and placed into 10% neutral formaldehyde buffer for
fixation. Other liver tissue was further divided into sev-
eral parts, kept in centrifuge tubes and stored at -80°C.
Indexes of observation and detection methods
Hematoxylin and eosin staining (HE) was used to de-
termine pathological changes of hepatic tissue. After
HE staining, degrees of lipid degeneration of liver cells
were observed under a light microscope[5].
Enzyme colorimetry analysis was used to determine
TG and FFA content in the liver tissue[6]. Lai's method
was used for detection of serum ALT and AST activi-
ties[7]. Detection of AMPK, FAS, ACCase, and Malo-
ny1-CoA liver tissue content were detected using ELI-
SA[8]. Expression of TNF-α and P-IkB protein in liver
tissue was detected using western blotting[9].
Statistical analyses
The data were statistically analyzed using the SPSS13.0
software package. The measurement data were ex-
pressed as mean ± standard deviation. One-way ANO-
VA and Q test were used for comparison among
groups.
RESULTS
Pathological changes in the liver tissue
The structure of hepatic lobules in the normal group
was complete. Liver cells were arranged in ropes and
distributed radiantly around the central vein, with ir-
regular multi-angle or oval forms. Cells were rich in cy-
toplasm, and no inflammatory cell infiltration was seen
in the hepatic lobules. Tumescent and soft liver tissue
could be seen macroscopically in the model group,
demonstrating an outward appearance of yellow-red al-
ternating with grey-red, along with a greasy appearance
of the tissue and section surface. Lipid degeneration
and full fat vacuoles in lobule cells could be seen under
the microscope. These cells were obviously affecting
the central region of the lobules. Infiltration of inflam-
matory cells, cell swelling, loose cytoplasm containing
large fat drops and nuclei pushed to one side of the cell
indicated that the model was effective. In the Zhi Zi
group, lipid degeneration and inflammatory response
were significantly alleviated as compared with the mod-
el group. Liver cell volume became smaller, hepatic lob-
ules were clearly delineated, and the fat droplet num-
ber was reduced (Figure 1).
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Table 1 Effects of Zhi Zi (Fructus Gardeniae) on TG, FFA, FAS, Malonyl-CoA, ACCase, AMPK contents in liver tissue ( xˉ ± S)
Group
Normal
Model
Zhi Zi
TG
(mg/g)
30±8
104±32ΔΔ
69±28**
FFA
(μmol/gprot)
63±11
186±37ΔΔ
98±26**
FAS
(nmol/gprot)
4.6±0.7
13.2±2.5ΔΔ
7.6±1.7*
Malonyl-CoA
(nmol/gprot)
0.4±0.08
1.5±0.19ΔΔ
0.8±0.12*
ACC
(nmol/gprot)
3.5±0.23
11.8±1.38ΔΔ
7.7±1.02*
AMPK
(IU/g)
1.3±0.12
0.5±0.07ΔΔ
0. 8±0.09*
Notes: ΔΔ P<0.01, vs. the normal group;* P<0.05,**P<0.01, vs. the model group.
Table 2 Effects of Zhi Zi ( Fructus Gardeniae) on Serum ALT
and AST Activities ( xˉ ± S)
Notes: ΔΔ P<0.01, vs. the normal group;* P<0.05, vs. the model
group.
Figure 1 Pathological diagram of liver tissues in the groups
(200x, HE staining). A: Normal group; B: Model group; C: Zhi
Zi group.
Figure 2 Effects of Zhi Zi (Fructus Gardeniae) on expressions
of P-IκB and TNF-α proteins. 1: normal group; 2: model
group; 3: Zhi Zi group.
Effect of Zhi Zi (Fructus Gardeniae) on TG, FFA,
FAS, Malonyl-CoA, ACCase, and AMPK content in
liver tissue
TG and FFA content in liver tissue of the model group
significantly increased when compared with rats in the
normal group, reaching 3.5 and 3 fold the levels, re-
spectively, seen in the normal group (P<0.01). The lev-
els of TG and FFA were significantly lower in the Zhi
Zi group than those in the model group (P<0.01). AC-
Case, Malony1-CoA, and FAS content in the liver tis-
sue were significantly increased (P<0.01) in the model
group, compared with the normal group. Contrasting-
ly, AMPK content significantly decreased in the model
group when compared with the normal group (P<
0.01). After treatment with Zhi Zi, ACCase, Malo-
ny1-CoA, and FAS content significantly decreased,
while AMPK content significantly increased (P<0.05;
see Table 1).
Effect of Zhi Zi (Fructus Gardeniae) on serum ALT
and AST activities
Compared with the normal group, serum ALT and
AST activities in the model group significantly in-
creased (P<0.01), and as compared with the model
group, serum ALT and AST activities in the Zhi Zi
group significantly decreased(P<0.05). See Table 2.
Effect of Zhi Zi (Fructus Gardeniae) on P-IκB and
TNF-α protein expression
Compared with the normal group, P-IκB and TNF-α
protein expression in the model group significantly in-
creased. A decreased expression of these proteins were
seen in the Zhi Zi group (Figure 2).
DISCUSSION
NAFLD is a kind of metabolism-related, irritable, lipoi-
dal liver injury closely related to insulin resistance and
genetic susceptibility. NAFLD can include non-alco-
holic simple fatty liver (NAFL), non-alcoholic steato-
hepatitis (NASH) and related cirrhosis of the liver and
hepatocellular carcinoma[10,11]. Although the exact mech-
anism is unclear, studies indicate that abnormal increas-
es in FFA plays a very important role in generation and
development of NAFL[12,13]. This study found that Zhi
Zi (Fructus Gardeniae) had very strong inhibitory ef-
fects on increases in TG and FFA content of liver tissue
in the rat model group, indicating that the pharmaco-
logical effects of Zhi Zi (Fructus Gardeniae) on
NAFLD are closely related to a decrease in FFA toxici-
ty.
AMPK, a class of important protein kinase, normally
improves metabolism of sugar and fat by promoting
skeletal muscle uptake of glucose, reducing output of
liver sugar, increasing oxidation of fatty acids, and in-
hibiting fatty acid synthesis[14-16]. However, during path-
ological conditions, after activation of AMPK, ACCase
converts downstream carboxylates acetyl coenzyme A
(acetyl-CoA) to Malonyl-CoA, and under the action of
FAS, with acetyl-CoA synthesizes FFA. This abnormal-
ly increases FFA, finally leading to TG synthesis and
fat deposition[16-18]. This study found that when com-
pared with the normal group, AMPK content de-
Group
Normal
Model
Zhi Zi
ALT (U/L)
41±7
126±35ΔΔ
79±28*
AST (U/L)
42±9
121±39ΔΔ
83±26*
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creased whilst ACCase, FAS, Malonyl-CoA, FFA, and
TG content increased in liver tissue from the model
group. These findings indicate that NAFLD affected
the free fatty acid metabolism pathway, with AMPK as
a starting point. Changes in this metabolic pathway
play a very important role in the occurrence and devel-
opment of fatty liver. Zhi Zi (Fructus Gardeniae) signif-
icantly increased AMPK content (being 1.6 fold that
of the model group), but decreased FAS, ACCase, Mal-
ony1-CoA, FFA, and TG content, suggesting that Zhi
Zi (Fructus Gardeniae) inhibited the fat deposition in
NAFLD and this action is closely related to the free fat-
ty acid metabolism pathway.
Modern studies indicate that FFA have very strong cel-
lular toxicity as degreasing agents, and activate I-κB ki-
nase β (IKK-β) through a lysosomal pathway, causing
I-κB phosphorylation, so as to start expression of the
inflammatory factor TNF-α, thereby inducing inflam-
matory injury of liver cells[19,20]. This study showed, that
compared with the normal group, serum ALT and
AST activities significantly increased, as did P-IκB and
TNF-α protein expression suggesting that FFA toxicity
plays an extremely important role in the inflammatory
injury of NAFLD. Interestingly, Zhi Zi (Fructus Garde-
niae) significantly decreased ALT and AST activities
(only being 62.7%, 68.6% of the model group), inhib-
ited phosphorylation of I-κB, and decreased expression
of TNF-α protein, which are closely related with the
inhibition of FFA toxicity.
Therefore, it can be seen that the metabolism pathway
of free fatty acids, with AMPK as a starting point,
causes abnormal increases in FFA and promotes accu-
mulation of TG. At the same time, abnormal increase
in FFA promotes TNF-α expression through a ribo-
somal pathway, leading to inflammatory injury, and fi-
nally forming the fat deposits of NAFLD and patholog-
ical changes seen following inflammatory injury. Zhi
Zi (Fructus Gardeniae) inhibited fat deposition and
strongly inhibited inflammatory injury. This observa-
tion may be based on an increase in AMPK content
and inhibition of the free fatty acid metabolism path-
way. Through inhibiting FFA toxicity, P-IκB and
TNF-α expression decreased, finally improving the
pathological state of NAFLD.
REFFERENCES
1 Chitturi S, Wong VE, Farrell G. Nonalcoholic fatty liver
in Asia: Firmly entrenched and rapidly gaining ground. J
Gastroenterol Hepatol 2011; 26: 163-172
2 Liang HQ, Chen SD, Zhang QQ, Huang JF. Experimen-
tal study on Yin Chen Hao Decoction for prevention and
treatment of non-alcoholic fatty hepatitis. Guangming
TCM 2009; 24: 212-214
3 Chen SD, Zhou HH, Li XM, Lin JP, Fan Y, Xu WJ.
Study on effective Chinese medical herbs in Yin Chen
Hao Decoction against fatty toxic action of free fatty acids
on HepG2 cells. Chinese Journal of Traditional Chinese
Medicine and Pharmacy 2010; 25: 1381-1384
4 Xu WJ, Fan Y, Chen SD, Zhou HH, Li G. Screening ef-
fective components of Yin Chen Hao Decoction against
abnormal lipid metabolism of fatty liver based on even de-
sign method. China Journal of Hospital Pharmacy 2011;
31: 274-277
5 Lin MT, Fan Y, Chen SD, Xu WJ, ZHOU HH, Li Jing,
Liu YH. Effect and mechanism of Yinchenhao Decoction
in preventing lipid metabolic disturbance for rats fed on
high fat diet. Chinese Journal of Traditional Chinese Medi-
cine and Pharmacy 2011; 26: 2428-2430
6 Zhang H, Feng Q, Li HS, Chen SD, Wang XN, Peng JH,
Zhang N, Hu YY. Effects of Qushi Huayu Dection on ca-
thepsin B and Tumor Necrosis Factor-a expression in rats
with non-alcoholic steatoheptitis. Journal of Chinese Inte-
grative Medicine 2008; 6: 928-933
7 Li HS, Feng Q, Hu YY, Chen SD, Li XM, Peng JH, Xu
LL, Liu C. Effect of Qushi Huayu Decoction on High fat
Diet Induced Hepatic Lipid Deposition in Rats. Chin J In-
tegr Med 2009; 29: 1092-1095
8 Li HS, Feng Q, Hu YY, Peng JH, Gu HT, Xu LL, Liu C.
Mechanism of Qushi Huayu Dection in Improving Metab-
olism of Free Acid in Fatty Acid in Fatty Liver Rats. Jour-
nal of Traditional Chinese Medicine 2010; 51: 262-264
9 Chen SD, Feng Qin, Peng JH, Xu LL, Liu P, Liu C, Hu
YY. Research of Herba Artemisiae Scoporiae inhibits the
hepatic lipotoxicity. China Journal of Chinese Materia
Medica 2009; 34: 2373-2378
10 Committee of Digestive System Diseases, China Society
of Integrated Chinese Medicine and Western Medicine.
Common opinions about combination of traditional Chi-
nese medicine with Western medicine for diagnosis and
treatment of non-alcoholic fatty hepatic disease. China
Journal of Integrated Traditional Chinese and Western
Medicine 2011; 31: 155-158
11 Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G.
Insulin resistance in nonalcoholic fatty liver disease. Curr
Pharm Des 2010; 16: 1945-1951
12 Gentile CL, Frye MA, Pagliassotti MJ. Fatty acids and en-
doplasmic reticulum in nonalcoholic fatty liver disease.
Biofactors 2011; 37: 8-16
13 Westerbacka J, Kotronen A, Fielding BA, Wahren J, Hod-
son L, Perttilä J, Seppänen-Laakso T, Suortti T, Arola J,
Hultcrantz R, Castillo S, Olkkonen VM, Frayn KN,
Orešič M, Yki-Järvinen H. Splanchnic balance of free fatty
acids, endocannabinoids, and lipids in subjects with nonal-
coholic fatty liver disease. Gastroenterology 2010; 139:
1961-1971
14 Ha SK, Kim J, Chae C. Role of AMP-activated protein ki-
nase and adiponectin during development of hepatic ste-
atosis in high-fat diet-induced obesity in rats. J Comp
Pathol 2011; 145: 88-94
15 Tian AP, Guo SS. AMP-activated protein kinase and Type
2 diabetes. Foreign Medicine. Endocrine Fascicle 2004;
24: 336-338
16 Song Z, Deaciuc I, Zhou Z, Song M, Chen T, Hill D, Mc-
Clain CJ. Involvement of AMP-activated protein kinase in
beneficial effects of betaine on high-sucrose diet-induced
hepatic steatosis. Am J Physiol Gastrointest Liver Physiol
85
JTCM |www. journaltcm. com March 15, 2012 | volume 32 | Issue 1 |
Chen SD et al. Effects of Zhi Zi (Fructus gardeniae) on non-alcoholic fatty liver disease in rat
2007; 293: 894-902
17 Savage DB, Choi CS, Samuel VT, Liu ZX, Zhang D,
Wang A, Zhang XM, Cline GW, Yu XX, Geisler JG, Bha-
not S, Monia BP, Shulman GI. Reversal of diet-induced
hepatic steatosis and hepatic insulin resistance by antisense
oligonucleotide inhibitors of acetyl-CoA carboxylases 1
and 2. J Clin Invest 2006; 116: 817824
18 OhW, Abu-Elheiga L, Kordari P, Gu Z, Shaikenov T, Chi-
rala SS, Wakil SJ. Glucose and Fat Metabolism in Adipose
Tissue of Acetyl-CoA Carboxylase 2 Knockout Mice.
Proc. Natl. Acad 2005; 102: 1384-1389
19 Feldstein AE, Werneburg NW, Li Z, Bronk SF, Gores GJ.
Bax inhibition protects against free fatty acid-induced lyso-
somal permeabilization. Am J Physiol Gastrointest Liver
Physiol 2006; 290: 1339-1346
20 Feldstein AE. Novel insights into the pathophysiology of
nonalcoholic fatty liver disease. Semin Liver Dis 2010; 30:
391-401
86
